BNCT for skin melanoma in extremities: Updated Argentine clinical results

Applied Radiation and Isotopes

Volumn 67, Issue 7-8 SUPPL., 2009, Pages

  Menendez P R ^a   Roth, B M C ^a   Pereira, M D ^a,b,c   Casal, M R ^a   Gonzalez S J ^b,d   Feld, D B ^b   Santa Cruz, G A ^b   Kessler, J ^b   Longhino, J ^b   Blaumann, H ^b   Jimenez Rebagliati R ^b   Calzetta Larrieu, O A ^b   Fernandez C ^b   Nievas, S I ^b   Liberman, S J ^b  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

^b DEPARTAMENTO DE FÍSICA   (Argentina)

^c Agencia Nacional de Promoción Científica y Tecnológica ^*  (Argentina)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

BNCT; BPA F; Clinical trials; Skin melanomas

Indexed keywords

ARGENTINA; ATOMIC ENERGY COMMISSIONS; BNCT; BPA-F; CLINICAL TRIAL; CLINICAL TRIALS; EPITHERMAL NEUTRON; MEAN AGES; NORMAL SKIN; NORMAL TISSUE;

TOXICITY;

SKIN;

4 BORONOPHENYLALANINE;

ADULT; AGED; ARGENTINA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG TUMOR LEVEL; FEMALE; HUMAN; HUMAN TISSUE; LEG DISEASE; MALE; MELANOMA; NEUTRON CAPTURE THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SKIN METASTASIS; SKIN ULCER; TREATMENT RESPONSE; TUMOR BIOPSY; VITILIGO;

AGED; ARGENTINA; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FEMALE; HUMANS; LEG; MALE; MELANOMA; MIDDLE AGED; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SKIN NEOPLASMS;

EID: 67649573672     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.03.020     Document Type: Article

References (16)

1. Archambeau J., Pezner R., and Wasserman T. Pathophysiology of irradiated skin and breast. Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 1171-1185
2. Blaumann H., González S., Longhino J., Santa Cruz G., Calzetta Larrieu O., Bonomi M., and Roth B. Boron neutron capture therapy of skin melanomas at the RA-6 reactor: a procedural approach to beam set up and performance evaluation for upcoming clinical trials. Med. Phys. 31 1 (2004) 70-80
3. Busse P., Zamenhof R., Madoc-Jones H., Solares G., Kiger S., Riley K., Chuang C., Rogers G., and Harling O. Clinical follow-up of patients with melanoma of extremity treated in phase I boron neutron capture therapy protocol. In: Larson B., Crawford J., and Weinreich R. (Eds). Advances in Neutron Capture Therapy vol. I (1997), Elsevier 60-64
4. Fukuda H., Honda C., Wadabayashi N., Kobayashi T., Yoshino K., Hiratsuka J., Takahashi J., Akaizawa T., Abe Y., Ichihashi M., and Mishima Y. Pharmacokinetics of 10B-p-boronophenylalanine in tumors, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma. Melanoma. Res. 9 (1999) 75-83
5. González, S.J., Santa Cruz, G.A., Kiger III, W.S., Goorley, J., Palmer, M., Buse, P., Zamenhof, R., 2002a. NCTPlan, the new PC version of MacNCTPlan: improvements and verification of a BNCT treatment planning system. In: Proceedings of the 10th International. Congress on Neutron Capture Therapy for Cancer, Monduzzi Editore, Bologna, pp. 557-561.
6. González, S., Santa Cruz, G., Kiger III, W., Zamenhof, R., 2002b. A new computational tool for constructing dose-volume histograms using combinatorial techniques. In: Proceedings of the 10th ICNCT, Monduzzi Editore, Bologna, pp. 629-633.
7. González S., Bonomi M., Santa Cruz G., Blaumann H., Calzetta Larrieu O., Menéndez P., Jiménez Rebagliati R., Longhino J., Feld D., Dagrosa M., Argerich C., Castiglia S., Batistoni D., Liberman S., and Roth B. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl. Radiat. Isot. 61 (2004) 1101-1105
8. 10B concentration ratios from clinical outcome of a BNCT treatment. Appl. Radiat. Isot. 61 (2004) 923-928
9. Habermalz H., and Fischer J. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer 38 (1976) 2258
10. Hiratsuka, J., Fukuda, H., Kobayashi, T., Yoshino, K., Honda, C., Ichihashi, M., Mishima, Y., 2000. Long term outcome of BNCT for malignant melanoma. In: Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, Osaka, pp. 165-166.
11. Hornsey S. The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma in patients. Br. J. Radiol. 51 (1978) 905
12. Liberman S., Dagrosa S., Jiménez Rebagliati R., Bonomi M., Roth B., Turjanski L., Castiglia S., González S., Menéndez P., Cabrini R., Roberti M., and Batistoni D. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina. Appl. Radiat. Isot. 61 (2004) 1095-1100
13. Mallesh J., Moore D., Allen B., McCarthy W., Jones R., and Stening W. The pharmacokinetics of p-boronophenylalanine-fructose in human patients with glioma and metastatic melanoma. Int. J. Radiat. Oncol. Biol. Phys. 28 (1994) 1183-1188
14. Mishima Y., Ichihashi M., Hatta S., Honda C., Yamamura K., and Nakagawa T. New thermal neutron capture therapy for malignant melanoma: melanogenesis-seeking 10B molecule-melanoma cell interaction from in vitro to first clinical trial. Pigment Cell. Res. 2 (1989) 226-234
15. Overgaard J. Radiation treatment of malignant melanoma. Int. J. Radiat. Oncol. Biol. Phys. 6 (1980) 41
16. Sause W.T., Cooper J.S., Rush S., Ago C., Cosmatos D., Coughlin C., Janjan N., and Lipsett J. Fraction size in external beam radiation therapy in the treatment of melanoma. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 429